These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Number II. Pemphigus vulgaris. Black M; Mignogna MD; Scully C Oral Dis; 2005 May; 11(3):119-30. PubMed ID: 15888101 [TBL] [Abstract][Full Text] [Related]
5. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris]. Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274 [TBL] [Abstract][Full Text] [Related]
6. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143 [TBL] [Abstract][Full Text] [Related]
7. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536 [TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related]
9. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide]. España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875 [TBL] [Abstract][Full Text] [Related]
10. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835 [TBL] [Abstract][Full Text] [Related]
11. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris. Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498 [TBL] [Abstract][Full Text] [Related]
12. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]
13. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Hacker MK; Janson M; Fairley JA; Lin MS Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237 [TBL] [Abstract][Full Text] [Related]
15. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446 [TBL] [Abstract][Full Text] [Related]
16. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706 [TBL] [Abstract][Full Text] [Related]
17. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817 [TBL] [Abstract][Full Text] [Related]
18. Pemphigus. Schmidt E; Kasperkiewicz M; Joly P Lancet; 2019 Sep; 394(10201):882-894. PubMed ID: 31498102 [TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice. Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S Front Immunol; 2018; 9():1935. PubMed ID: 30233569 [TBL] [Abstract][Full Text] [Related]